The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system

30Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Implementation of pharmacogenomics (PGx) in clinical care can lead to improved drug efficacy and reduced adverse drug reactions. However, there has been a lag in adoption of PGx tests in clinical practice. This is due in part to a paucity of rigorous systems for translating published clinical and scientific data into standardized diagnostic tests with clear therapeutic recommendations. Here we describe the Pharmacogenomics Appraisal, Evidence Scoring and Interpretation System (PhAESIS), developed as part of the Coriell Personalized Medicine Collaborative research study, and its application to seven commonly prescribed drugs. © 2013 Gharani et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Gharani, N., Keller, M. A., Stack, C. B., Hodges, L. M., Schmidlen, T. J., Lynch, D. E., … Christman, M. F. (2013). The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. Genome Medicine, 5(10). https://doi.org/10.1186/gm499

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free